292 related articles for article (PubMed ID: 37645246)
1. Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers.
Lavudi K; Nuguri SM; Olverson Z; Dhanabalan AK; Patnaik S; Kokkanti RR
Front Cell Dev Biol; 2023; 11():1254612. PubMed ID: 37645246
[TBL] [Abstract][Full Text] [Related]
2. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
Ozpolat B; Mehta K; Lopez-Berestein G
Leuk Lymphoma; 2005 Oct; 46(10):1497-506. PubMed ID: 16194896
[TBL] [Abstract][Full Text] [Related]
3. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
4.
Facey COB; Hunsu VO; Zhang C; Osmond B; Opdenaker LM; Boman BM
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254755
[No Abstract] [Full Text] [Related]
5. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
[TBL] [Abstract][Full Text] [Related]
6. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994 Jun; 8(6):914-7. PubMed ID: 8207983
[TBL] [Abstract][Full Text] [Related]
7. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
[TBL] [Abstract][Full Text] [Related]
9. The success and the challenge of all-trans retinoic acid in the treatment of cancer.
Ni X; Hu G; Cai X
Crit Rev Food Sci Nutr; 2019; 59(sup1):S71-S80. PubMed ID: 30277803
[TBL] [Abstract][Full Text] [Related]
10. Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers.
Idres N; Marill J; Flexor MA; Chabot GG
J Biol Chem; 2002 Aug; 277(35):31491-8. PubMed ID: 12070176
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity.
Quere R; Baudet A; Cassinat B; Bertrand G; Marti J; Manchon L; Piquemal D; Chomienne C; Commes T
Blood; 2007 May; 109(10):4450-60. PubMed ID: 17218384
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
Zhang JW; Wang JY; Chen SJ; Chen Z
J Biosci; 2000 Sep; 25(3):275-84. PubMed ID: 11022230
[TBL] [Abstract][Full Text] [Related]
13. PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APL.
Tabe Y; Konopleva M; Kondo Y; Contractor R; Tsao T; Konoplev S; Shi Y; Ling X; Watt JC; Tsutsumi-Ishii Y; Ohsaka A; Nagaoka I; Issa JP; Kogan SC; Andreeff M
Cancer Biol Ther; 2007 Dec; 6(12):1967-77. PubMed ID: 18075297
[TBL] [Abstract][Full Text] [Related]
14. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
15. Retinoids as Chemo-Preventive and Molecular-Targeted Anti-Cancer Therapies.
Hunsu VO; Facey COB; Fields JZ; Boman BM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299349
[TBL] [Abstract][Full Text] [Related]
16. Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy.
Martino OD; Welch JS
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31805753
[TBL] [Abstract][Full Text] [Related]
17. The immunomodulatory role of all-trans retinoic acid in tumor microenvironment.
Bi G; Liang J; Bian Y; Shan G; Besskaya V; Wang Q; Zhan C
Clin Exp Med; 2023 Jul; 23(3):591-606. PubMed ID: 35829844
[TBL] [Abstract][Full Text] [Related]
18. Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells.
García-Regalado A; Vargas M; García-Carrancá A; Aréchaga-Ocampo E; González-De la Rosa CH
Mol Cancer; 2013 May; 12():44. PubMed ID: 23693014
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
[TBL] [Abstract][Full Text] [Related]
20. Effect of NADPH-cytochrome P450 reductase on all-trans-retinoic acid efficacy and cytochrome P450 26A1 expression in human myeloid leukaemia HL-60 cells.
Hu L; Lv JF; Zhuo W; Zhang CM; Zhou HH; Fan L
J Pharm Pharmacol; 2016 Sep; 68(9):1193-202. PubMed ID: 27366899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
